Country: Malta
Language: English
Source: Medicines Authority
METHADONE HYDROCHLORIDE
Alkaloid-INT d.o.o. Šlandrova ulica 4, 1231 Ljubljana-Crnuce, Slovenia
N07BC02
METHADONE HYDROCHLORIDE 1 mg/ml
ORAL SOLUTION
METHADONE HYDROCHLORIDE 1 mg/ml
POM
OTHER NERVOUS SYSTEM DRUGS
Authorised
2019-06-05
PACKAGE LEAFLET: INFORMATION FOR THE USER METHADONE ALKALOID 1 MG/ML ORAL SOLUTION Methadone hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Methadone Alkaloid is and what it is used for 2. What you need to know before you take Methadone Alkaloid 3. How to take Methadone Alkaloid 4. Possible side effects 5. How to store Methadone Alkaloid 6. Contents of the pack and other information 1. WHAT METHADONE ALKALOID IS AND WHAT IT IS USED FOR This medicine contains methadone hydrochloride, which belongs to a group of medicines called narcotic analgesics. It is used as part of the treatment of opioid addiction. All patients receiving Methadone Alkaloid must be routinely monitored for signs of misuse, abuse, and addiction during treatment. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE METHADONE ALKALOID DO NOT TAKE METHADONE ALKALOID IF: - you are allergic to methadone or any of the other ingredients of this medicine (listed in section 6). An allergic reaction includes a rash, itching or shortness of breath; - you are having an asthma attack. You should not use this medicine during an asthma attack. If you give this medicine to yourself (self-administration), wait until the asthma attack has passed and you are fully recovered; - your breathing is very slow or shallow (respiratory depression); - you are addicted to alcohol; - you have suffered a recent head injury or have an increased pressure in the brain; - you are taking monoamine oxidase inhibitors (MAOIs) used to treat depression or if you Read the complete document
Page 1 of 15 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Methadone Alkaloid 1 mg/ml oral solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of the oral solution contains 1 mg of methadone hydrochloride. Excipients with known effect: Sorbitol (E420): 21.0 mg per 1 ml Sodium Benzoate (E211): 3.0 mg per 1 ml Sunset Yellow FCF (E110): 0.009 mg per 1ml Each 1 ml of the oral solution contains 0.478 mg (0.021 mmol) sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral solution Clear green solution 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Substitution therapy for maintenance of opioid dependence in adults in conjunction with appropriate medical, social and psychosocial care. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For oral administration only. This medicinal product should always be taken orally with or without food. This product must not be injected. Dosage should be titrated to individual needs of patients. Local clinical guidance may differ from the posology described hereafter and should be followed. Substitution treatment with methadone should be prescribed by a doctor with experience in treating opiate/opioid-dependent patients, preferably at centres that have specialised in the treatment of opiate/opioid dependency. The dose is administered exclusively by the doctor or someone appointed by the doctor. The amount to be taken is never measured by the patient. The appropriate dose is given to the patient for immediate use only and used as directed by the doctor. Page 2 of 15 The dose is based on the occurrence of withdrawal symptoms and must be adjusted for each patient according to his or her individual situation and the way he or she feels. In general, after adjustment of the dose, the aim is to administer the lowest possible maintenance dose. _Adults_ In general the initial dose will be between 10-30 mg. The first dose given to a patient who has not recently used opioids should be no greater than 10-20 mg. In cases where tole Read the complete document